Dr. Slade specializes in the clinical care of patients with multiple myeloma and related plasma cell disorders, with a focus on bone marrow transplant and cellular immunotherapy. His research interests include improving response to immunotherapy for multiple myeloma and customizing cancer treatment based on sensitive markers of myeloma remission.